The European Medical Information Framework consortium has assembled electronic health record (EHR) databases for dementia research. We calculated dementia prevalence and incidence in 25 million persons from 2004 to 2012. Read & Research Alzheimer’s More

Be the first to comment
            

One in 3 cases of dementia can be prevented by managing key lifestyle factors, such as engaging in more physical exercise and social activities. Read & Research Alzheimer’s More

Be the first to comment
            

The traditional view that protein buildup in the brain causes Alzheimer’s disease is being challenged, and new evidence brings hope of novel drug targets. Read & Research Alzheimer’s More

Be the first to comment
            

New studies reveal links between complex tasks in early life, targeted physical and brain training in later life, and levels of cognition. Read & Research Alzheimer’s More

Be the first to comment
            

Blood screening tests to detect levels of an Alzheimer’s disease marker in the blood may help to predict disease risk and even work to prevent it. Read & Research Alzheimer’s More

Be the first to comment
            

New discovery in motor neurone disease and dementia could pave the way to novel treatments. Read & Research Alzheimer’s More

Be the first to comment
            

Cerebrospinal fluid analysis and other measurements of amyloidosis, such as amyloid-binding positron emission tomography studies, are limited by cost and availability. There is a need for a more practical amyloid β (Aβ) biomarker for central nervous system amyloid deposition. Read & Research Alzheimer’s More

Be the first to comment
            

In a study deemed a ‘massive undertaking’ by the researchers, two new genes have been found that may contribute to the development of Alzheimer’s. Read & Research Alzheimer’s More

Be the first to comment
            

We read with great interest the recent article by Herring et al. [1], who presented a highly detailed explication of potential roles for kallikrein 8 (KLK8) in Alzheimer’s disease (AD); their work highlights how KLK8 inhibition attenuates AD pathology in mice [1]. They illustrated increased KLK8 protein in AD brain, progressing Read & Research Alzheimer’s More

Be the first to comment
            

Members of the Faculty of Fundamental Medicine at the Lomonosov Moscow State University have determined the structure of a peptide complex, formed in the brain at the early stages of Alzheimer’s… Read & Research Alzheimer’s More

Be the first to comment
            

Hyposmia is a term describing partial or complete loss of the sense of smell. Learn about the causes, how it is treated, and related conditions. Read & Research Alzheimer’s More

Be the first to comment
            

A series of studies sheds new light on the racial disparities among Americans living with Alzheimer’s disease. Stress and social adversity play a key role. Read & Research Alzheimer’s More

Be the first to comment
            

It is hypothesized that cerebral hypoperfusion promotes the development of Alzheimer pathology. We therefore studied whether longstanding cerebral hypoperfusion is associated with Alzheimer pathology in nondemented humans. Read & Research Alzheimer’s More

Be the first to comment
            

Research linking traumatic brain injury and dementia later in life is contradictory. Learn about the latest findings and what they mean for TBI patients. Read & Research Alzheimer’s More

Be the first to comment
            

Cinnamon is a widely-used spice in cooking, but Ceylon cinnamon may also help protect against diabetes, Alzheimer’s disease, and other conditions. Read & Research Alzheimer’s More

Be the first to comment
            

The best-established cerebrospinal fluid (CSF) biomarkers for Alzheimer’s disease are levels of amyloid-β 42 (Aβ42), total tau (tau), and phosphorylated tau 181 (ptau). We examined whether a widely used commercial immunoassay for CSF Aβ42, tau, and ptau provided stable measurements for more than ∼10 years. Read & Research Alzheimer’s More

Be the first to comment
            

To examine the risk of Alzheimer’s disease (AD) among cancer survivors in a national database. Read & Research Alzheimer’s More

Be the first to comment
            

For nearly 50 years, institutional review boards (IRB) and independent ethics committees have featured local oversight as a core function of research ethics reviews. However growing complexity in Alzheimer’s clinical research suggests current approaches to research volunteer safety is hampering development of new therapeutics. As a partial response to this Read & Research Alzheimer’s More

Be the first to comment
            

New study shows that disruption of slow wave sleep raises amyloid beta, and repeated poor sleep quality raises tau – both hallmarks of Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment
            

Researchers reveal that fisetin, a compound found in strawberries and other fruits and vegetables, reduced cognitive decline in mouse models of aging. Read & Research Alzheimer’s More

Be the first to comment
            

We read with great interest the elegant work by Pascoal et al. [1] describing a synergistic effect between florbetapir uptake values and cerebrospinal fluid (CSF) p-tau levels on the 2-year risk of progression to Alzheimer’s disease (AD) dementia in patients with amnestic mild cognitive impairment (aMCI) from the Alzheimer Disease Neuroimaging Read & Research Alzheimer’s More

Be the first to comment
            

Response letter"> Response letter

Posted July 7, 2017 By

In the letter “A cardinal sin when researching neuropsin: Thou shalt validate antibodies,” Lahiri et al. respond to a study published this December by Herring et al. in Alzheimer’s & Dementia. More specifically, they criticize Herring et al. for an apparent “lack of information on antibody validation”; in particular, they question the antibody Read & Research Alzheimer’s More

Be the first to comment
            

The etiologies of dementia are complex and influenced by genetic and environmental factors including medical conditions. Read & Research Alzheimer’s More

Be the first to comment
            

The hallmark of many neurodegenerative diseases is the formation of protein aggregates, yet how and why these aggregates form remains a mystery. Read & Research Alzheimer’s More

Be the first to comment
            

A moderate to severe traumatic brain injury may increase the risk of dementia, a new study finds, particularly if the injury occurs in middle age. Read & Research Alzheimer’s More

Be the first to comment
            

New research finds biological markers for Alzheimer’s disease in the spinal fluid of people who report poor sleep quality or who have trouble sleeping. Read & Research Alzheimer’s More

Be the first to comment
            

Researchers at the Medical Research Council Laboratory of Molecular Biology (LMB) have, for the first time, revealed the atomic structures of one of the two types of the abnormal filaments which lead… Read & Research Alzheimer’s More

Be the first to comment
            

New research finds an enzyme that enhances the neurotoxicity of both Parkinson’s and Alzheimer’s disease. Inhibiting this enzyme may prevent Parkinson’s. Read & Research Alzheimer’s More

Be the first to comment
            

For the first time, researchers at the University of Zurich have demonstrated a surprising effect of microglia, the scavenger cells of the brain: If these cells lack the TDP-43 protein, they not only… Read & Research Alzheimer’s More

Be the first to comment
            

People with Alzheimer’s disease who experience psychosis – including delusions and hallucinations – are five times more likely to be misdiagnosed with dementia with Lewy bodies compared to patients… Read & Research Alzheimer’s More

Be the first to comment